一例肛门腺腺癌的个案报道并文献回顾
Adenocarcinoma of the Anal Glands: A Case Report and Literature Review
DOI: 10.12677/acm.2024.14102713, PDF,   
作者: 石光浩:西安医学院研究生工作部,陕西 西安;常伟平*:西安医学院第一附属医院胃肠肛肠外科,陕西 西安
关键词: 肛门腺腺癌结直肠癌个案报道Adenocarcinoma of the Anal Glands Colorectal Cancer Case Report
摘要: 迄今为止,文献仅包含少数肛门腺腺癌病例的报道。肛门腺腺癌是结直肠癌的一种罕见亚型,由于在足够患者群体的情况下进行大规模研究的挑战,因此对其管理的共识变得复杂。本报告详细介绍了一例罕见的肛门腺腺癌病例,该病例在术中探查期间偶然发现。该病例涉及一名46岁女性,因肛周疼痛到门诊部就诊。体格检查显示阴道旁肿块约1厘米。影像学检查显示存在直肠阴道瘘。对病变进行手术切除。手术后患者出院情况良好。病理检查显示肛门腺腺癌。术后进行了化疗,患者仍然存活,没有复发的证据。因其无特异性临床表现,故时常发生漏诊、误诊,甚至有时伴随其他疾病的诊疗过程中检出。本文就一例肛门腺腺癌的病例做相关报道并针对性进行文献综述。
Abstract: To date, the literature contains reports of only a few cases of adenocarcinoma of the anal glands. Adenocarcinoma of the anal glands represents a rare subtype of colorectal cancer, complicating the consensus on its management due to the challenge of conducting large-scale studies with an adequate patient population. This report details a rare case of adenocarcinoma of the anal glands, fortuitously identified during intraoperative exploration. This case involves a 46-year-old female who presented to the outpatient department with perianal pain. Physical examination revealed a paravaginal mass measuring approximately 1 centimeter. Imaging studies demonstrated the presence of a rectovaginal fistula. Surgical resection of the lesion was performed. Following surgery, the patient was discharged in good condition. Pathological examination revealed adenocarcinoma of the anal glands. Postoperative chemotherapy was administered, and the patient remains alive and well without evidence of relapse. Owing to its non-specific clinical manifestations, it often leads to missed or incorrect diagnoses, and sometimes may be detected during the diagnosis and treatment of other diseases. This article reports on a case of anal gland adenocarcinoma and conducts a targeted literature review.
文章引用:石光浩, 常伟平. 一例肛门腺腺癌的个案报道并文献回顾[J]. 临床医学进展, 2024, 14(10): 680-685. https://doi.org/10.12677/acm.2024.14102713

参考文献

[1] Benson, A.B., Venook, A.P., Al-Hawary, M.M., Arain, M.A., Chen, Y., Ciombor, K.K., et al. (2021) Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 19, 329-359. [Google Scholar] [CrossRef] [PubMed]
[2] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[3] Qiu, H., Cao, S. and Xu, R. (2021) Cancer Incidence, Mortality, and Burden in China: A Time-Trend Analysis and Comparison with the United States and United Kingdom Based on the Global Epidemiological Data Released in 2020. Cancer Communications, 41, 1037-1048. [Google Scholar] [CrossRef] [PubMed]
[4] Young, A.N., Jacob, E., Willauer, P., Smucker, L., Monzon, R. and Oceguera, L. (2020) Anal Cancer. Surgical Clinics of North America, 100, 629-634. [Google Scholar] [CrossRef] [PubMed]
[5] Japanese Society for Cancer of the Colon and Rectum (2019) Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: The 3d English Edition [Secondary Publication]. Journal of the Anus, Rectum and Colon, 3, 175-195. [Google Scholar] [CrossRef] [PubMed]
[6] Wong, M.T., Lim, J.F. and Eu, K.W. (2011) Anal Canal Malignancies: A Review in an Asian Population. Singapore Medical Journal, 52, 9-14.
[7] Eng, C., Ciombor, K.K., Cho, M., Dorth, J.A., Rajdev, L.N., Horowitz, D.P., et al. (2022) Anal Cancer: Emerging Standards in a Rare Disease. Journal of Clinical Oncology, 40, 2774-2788. [Google Scholar] [CrossRef] [PubMed]
[8] Urbute, A., Munk, C., Sand, F.L., Belmonte, F. and Kjaer, S.K. (2022) Trends in Incidence and Survival from Anal Cancer and Incidence of High-Grade Anal Intraepithelial Neoplasia in Denmark. Cancer Epidemiology, 77, Article 102099. [Google Scholar] [CrossRef] [PubMed]
[9] Shin, I.Y., Sung, N.Y., Lee, Y.S., Kwon, T.S., Si, Y., Lee, Y.S., et al. (2014) The Expression of Multiple Proteins as Prognostic Factors in Colorectal Cancer: Cathepsin D, P53, COX-2, Epidermal Growth Factor Receptor, C-erbB-2, and Ki-67. Gut and Liver, 8, 13-23. [Google Scholar] [CrossRef] [PubMed]
[10] Ryan, D.P., Compton, C.C. and Mayer, R.J. (2000) Carcinoma of the Anal Canal. New England Journal of Medicine, 342, 792-800. [Google Scholar] [CrossRef] [PubMed]
[11] Siegel, R., Werner, R.N., Koswig, S., et al. (2021) Clinical Practice Guideline: Anal Cancer—Diagnosis, Treatment and Follow-Up. Deutsches Ärzteblatt International, 118, 217-224.
[12] Patcharatrakul, T. and Rao, S.S.C. (2018) Update on the Pathophysiology and Management of Anorectal Disorders. Gut and Liver, 12, 375-384. [Google Scholar] [CrossRef] [PubMed]
[13] Valvo, F., Ciurlia, E., Avuzzi, B., Doci, R., Ducreux, M., Roelofsen, F., et al. (2019) Cancer of the Anal Region. Critical Reviews in Oncology/Hematology, 135, 115-127. [Google Scholar] [CrossRef] [PubMed]
[14] Yasuhara, M., Beppu, N., Uchino, M., Ikeuchi, H., Matsuda, I., Hirota, S., et al. (2020) Adverse Oncologic Outcomes of Adenocarcinoma of the Anal Canal in Patients with Crohn’s Disease. Diseases of the Colon & Rectum, 64, 409-419. [Google Scholar] [CrossRef] [PubMed]
[15] Chang, G.J., Gonzalez, R.J., Skibber, J.M., Eng, C., Das, P. and Rodriguez-Bigas, M.A. (2009) A Twenty-Year Experience with Adenocarcinoma of the Anal Canal. Diseases of the Colon & Rectum, 52, 1375-1380. [Google Scholar] [CrossRef] [PubMed]
[16] Chatani, P.D., Dominguez, D.A., Aversa, J.G., Davis, J.L., Hernandez, J.M., Lai, L.L., et al. (2021) Local Excision and Chemoradiation for Clinical Node-Negative Anal Adenocarcinoma. Surgical Oncology, 37, Article 101551. [Google Scholar] [CrossRef] [PubMed]
[17] Iesalnieks, I., Gaertner, W.B., Gla, H., Strauch, U., Hipp, M., Agha, A., et al. (2010) Fistula-Associated Anal Adenocarcinoma in Crohnʼs Disease. Inflammatory Bowel Diseases, 16, 1643-1648. [Google Scholar] [CrossRef] [PubMed]
[18] Peiffert, D., Tournier-Rangeard, L., Gérard, J., Lemanski, C., François, E., Giovannini, M., et al. (2012) Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial. Journal of Clinical Oncology, 30, 1941-1948. [Google Scholar] [CrossRef] [PubMed]
[19] Lukovic, J., Kim, J.J., Krzyzanowska, M., Chadi, S.A., Taniguchi, C.M. and Hosni, A. (2020) Anal Adenocarcinoma: A Rare Malignancy in Need of Multidisciplinary Management. JCO Oncology Practice, 16, 635-640. [Google Scholar] [CrossRef] [PubMed]
[20] Harpain, F., Dawoud, C., Wimmer, K., Schlager, L., Kirchnawy, S., Rizk, D., et al. (2023) Fistula-Associated Anal Adenocarcinoma: A 20-Year Single-Center Experience. Annals of Surgical Oncology, 30, 3517-3527. [Google Scholar] [CrossRef] [PubMed]